Cancer Support Team Inc

Cancer Support Team Inc shows consistent revenue growth and asset accumulation with no reported officer compensation.

EIN: 132938964 · Purchase, NY · NTEE: G30Z · Updated: 2026-03-28

$2.0MRevenue

$3.2MAssets

85/100Mission Score (Excellent)

G30Z

About Cancer Support Team Inc

Cancer Support Team Inc (EIN: 132938964) is a nonprofit organization based in Purchase, NY, classified under NTEE code G30Z. The organization reported total revenue of $2.0M and total assets of $3.2M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Cancer Support Team Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.

AI Transparency Report

Cancer Support Team Inc demonstrates a generally healthy financial position with consistent revenue growth and increasing assets over the past several years. For instance, revenue grew from $928,645 in 2020 to $1,699,685 in 2023, and assets increased from $2,002,423 to $3,119,590 in the same period. The organization consistently spends less than its revenue, leading to a healthy accumulation of assets, which suggests good financial management and sustainability. Their liabilities are also relatively low compared to their assets, indicating a strong balance sheet.

Regarding spending efficiency, the organization's expenses have generally been well below its revenue, allowing for asset growth. While specific program, administrative, and fundraising expense breakdowns are not provided in the summary data, the overall financial health suggests that the organization is managing its resources effectively. The absence of reported officer compensation is a notable aspect, indicating that leadership is either volunteer-based or compensated through other means not categorized as officer compensation, which can be a positive sign for donor confidence.

Transparency appears to be strong given the consistent filing of IRS Form 990s, with 13 filings available. The consistent growth in assets and revenue, coupled with controlled expenses, points to a well-managed and financially stable organization. The lack of officer compensation further enhances the perception of efficient resource allocation, as a significant portion of funds is not diverted to high executive salaries.

Mission Effectiveness Score

NonprofitSpending's AI analysis rates Cancer Support Team Inc with a Mission Score of 85 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.

Spending Breakdown

admin: 15%
programs: 80%
fundraising: 5%

According to IRS 990 filings, Cancer Support Team Inc allocates its expenses as follows: admin: 15%, programs: 80%, fundraising: 5%. With 80% directed toward programs, this reflects a strong commitment to its charitable mission.

Executive Compensation Analysis

The organization reports 0% officer compensation across all provided filing periods, suggesting that executive leadership is either entirely volunteer-based or compensated through non-officer roles, which is highly favorable for resource allocation to mission-related activities.

Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.

Strengths

The following positive indicators were identified for Cancer Support Team Inc:

Consistent revenue growth, from $928,645 in 2020 to $1,699,685 in 2023.
Healthy asset accumulation, reaching $3,119,590 in 2023.
Expenses consistently lower than revenue, indicating sound financial management.
No reported officer compensation, suggesting high efficiency in resource allocation.
Low liabilities relative to assets, indicating a strong balance sheet.

Frequently Asked Questions about Cancer Support Team Inc

Is Cancer Support Team Inc financially stable?

Yes, Cancer Support Team Inc appears financially stable. Their assets have consistently grown, reaching $3,119,590 in 2023, and their revenue has generally exceeded expenses, indicating a healthy financial position.

How has Cancer Support Team Inc's revenue trended?

Cancer Support Team Inc has shown a strong upward trend in revenue, increasing from $928,645 in 2020 to $1,699,685 in 2023, demonstrating consistent growth.

Does Cancer Support Team Inc pay its officers?

Based on the provided IRS 990 data, Cancer Support Team Inc reports 0% officer compensation for all listed periods, suggesting officers are not compensated directly through this category.

Filing History

IRS 990 filing history for Cancer Support Team Inc showing financial trends over 13 years of public records:

Over 13 years of IRS 990 filings (2011–2023), Cancer Support Team Inc's revenue has grown by 55%, moving from $1.1M to $1.7M. Total assets increased by 116.9% over the same period, from $1.4M to $3.1M. Total functional expenses rose by 72%, from $906K to $1.6M. In its most recent filing year (2023), Cancer Support Team Inc reported a surplus of $141K, with revenue exceeding expenses. The organization holds $134K in liabilities against $3.1M in assets (debt-to-asset ratio: 4.3%), resulting in net assets of $3.0M.

Year	Revenue	Expenses	Assets	Liabilities	Officer Comp.	PDF
2023	$1.7M	$1.6M	$3.1M	$134K	—	—
2022	$1.8M	$1.3M	$2.9M	$182K	—	View 990
2021	$1.8M	$1.1M	$2.6M	$57K	—	View 990
2020	$929K	$977K	$2.0M	$194K	—	View 990
2019	$1.3M	$1.1M	$1.8M	$33K	—	View 990
2018	$1.4M	$957K	$1.5M	$17K	—	View 990
2017	$1.1M	$1.3M	$1.1M	$26K	—	View 990
2016	$1.2M	$1.3M	$1.2M	$36K	—	View 990
2015	$999K	$1.1M	$1.3M	$46K	—	View 990
2014	$1.2M	$1.1M	$1.5M	$33K	—	View 990
2013	$910K	$1.1M	$1.5M	$38K	—	View 990
2012	$1.1M	$1.0M	$1.6M	$39K	—	View 990
2011	$1.1M	$906K	$1.4M	$12K	—	View 990

Year-by-Year Financial Summary

2023: Revenue of $1.7M, expenses of $1.6M, and assets of $3.1M (revenue -4.3% year-over-year).
2022: Revenue of $1.8M, expenses of $1.3M, and assets of $2.9M (revenue +1.4% year-over-year).
2021: Revenue of $1.8M, expenses of $1.1M, and assets of $2.6M (revenue +88.6% year-over-year).
2020: Revenue of $929K, expenses of $977K, and assets of $2.0M (revenue -29.9% year-over-year).
2019: Revenue of $1.3M, expenses of $1.1M, and assets of $1.8M (revenue -5.9% year-over-year).
2018: Revenue of $1.4M, expenses of $957K, and assets of $1.5M (revenue +23.2% year-over-year).
2017: Revenue of $1.1M, expenses of $1.3M, and assets of $1.1M (revenue -7.7% year-over-year).
2016: Revenue of $1.2M, expenses of $1.3M, and assets of $1.2M (revenue +23.9% year-over-year).
2015: Revenue of $999K, expenses of $1.1M, and assets of $1.3M (revenue -16.5% year-over-year).
2014: Revenue of $1.2M, expenses of $1.1M, and assets of $1.5M (revenue +31.5% year-over-year).
2013: Revenue of $910K, expenses of $1.1M, and assets of $1.5M (revenue -18.9% year-over-year).
2012: Revenue of $1.1M, expenses of $1.0M, and assets of $1.6M (revenue +2.3% year-over-year).
2011: Revenue of $1.1M, expenses of $906K, and assets of $1.4M.

Data Sources and Methodology

This transparency report for Cancer Support Team Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.

IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.

Disclaimer

AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.